<ѻý>T1D Patient Achieves Full Insulin Independence After Stem Cell Transplantѻý> But clinical trial currently under FDA hold as dosing is discussed Jun 06, 2022
<ѻý>Tirzepatide Reduced Albuminuria in T2D Patients With Heart Riskѻý> Subanalysis of SURPASS-4 trial compared the GLP-1/GIP agonist against insulin glargine Jun 06, 2022
<ѻý>Can Longstanding BP Meds Protect Against Brain Aneurysm Ruptures?ѻý> RAAS inhibitors could be therapy of choice for those with hypertension and intracranial aneurysms Jun 06, 2022
<ѻý>Is Diabetes a Risk Factor for Long COVID? Possibly.ѻý> Mixed results in seven-study scoping review Jun 05, 2022
<ѻý>Dulaglutide Improves HbA1c for Youth With Type 2 Diabetesѻý> Safety profile consistent with that reported in adults Jun 05, 2022
<ѻý>Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesityѻý> SURMOUNT-1 trial tested GIP/GLP-1 receptor agonist in people without diabetes Jun 05, 2022
<ѻý>No Cardioprotection Seen With Long-Term Metformin or Lifestyle Interventionѻý> Both approaches "highly effective" in T2D, but not for preventing CV disease, expert says May 24, 2022
<ѻý>TAVR for Aortic Regurgitation Off to a Good Start in the Real Worldѻý> Yet some growing pains remain for the Jenavalve Trilogy May 21, 2022
<ѻý>No-Implant Shunt Eases HF Symptoms in Early Dataѻý> Quality of life consistently improved across first-in-man studies May 20, 2022
<ѻý>TAVR Stays Its Course as 10-Year Durability Data Trickle Inѻý> Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
<ѻý>Renal Denervation Responders Hint at Good Clinical Outcomesѻý> A taste of clinical outcomes data when a randomized trial is unlikely May 17, 2022
<ѻý>Diabetic Pain Relief Lasts With High Frequency Spinal Cord Stimulationѻý> Trial followed patients with Senza System for 18 months May 16, 2022
<ѻý>Patients With Type 2 Diabetes and CKD Face Poor COVID Outcomesѻý> Severity of kidney disease ups risk of ICU time, in-hospital mortality, and more May 15, 2022
<ѻý>First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetesѻý> Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
<ѻý>Black Kids From Poorer Neighborhoods Hit Hardest by DKA Readmissionsѻý> But even those in areas with better resources faced disparities versus other children May 05, 2022
<ѻý>How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease?ѻý> Study finds estimated annual progression rate to diabetes of 5.3% Apr 20, 2022
<ѻý>Who Is Really Driving Up Insulin Costs?ѻý> More attention needs to focus on pharmaceutical middlemen Apr 18, 2022
<ѻý>In Type 2 Diabetes, Metabolic Control Could Add Years to Lifeѻý> Controlling four biomarkers could add as much as a decade to life expectancy Apr 18, 2022
<ѻý>Novel Agents Promising in Pruritus, Rare Metabolic Disease, and Moreѻý> A round-up of noteworthy research from the NKF Spring Clinical Meetings Apr 10, 2022
<ѻý>Novel Drug Cuts Proteinuria in APOL1-Mediated Kidney Diseaseѻý> Significant UPCR reductions in just a few weeks in phase II study Apr 10, 2022
<ѻý>Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bayѻý> Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
<ѻý>Systemic Corticosteroids in Acute HF: Worth Another Look?ѻý> Some see a potential treatment for patients with more inflammation Apr 08, 2022
<ѻý>Which Factors Predict Rapid Decline in Polycystic Kidney Disease?ѻý> Researchers pinpointed six clinical variables predictive of rapid decline to ESRD Apr 08, 2022
<ѻý>Flu a Consistent Threat to ESRD Patientsѻý> Those with advanced-stage kidney disease had 28% higher risk of in-hospital death Apr 08, 2022
<ѻý>The Winners and Losers of the Proposed Insulin Cost Capѻý> While it benefits some, the $35 cap is only a stopgap measure Apr 08, 2022
<ѻý>COVID-Related AKI Chronically Hard on Kidneysѻý> More critically ill COVID patients developed CKD versus bacterial pneumonia patients Apr 08, 2022
<ѻý>Which Anticonvulsant Mood Stabilizer Upped Diabetes Risk?ѻý> Observational study looked at 5-year risk differences between four agents Apr 06, 2022
<ѻý>Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HFѻý> Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
<ѻý>EHR Pop-Ups Spur Better GDMT Implementation in Heart Failureѻý> Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
<ѻý>Tide Turns on Withholding Blood Pressure Meds for Pregnant Womenѻý> Antihypertensive treatment was safe for mothers and children in the CHAP trial Apr 02, 2022
<ѻý>Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Eventsѻý> Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
<ѻý>From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classesѻý> Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
<ѻý>Pumping (IV) Iron Linked to Varying Anaphylaxis Risk for Older Adultsѻý> Study finds risk was low, but unequal across different products Mar 28, 2022
<ѻý>GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder?ѻý> Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug Mar 28, 2022
<ѻý>In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor?ѻý> EMPEROR-Preserved trial weighs in Mar 21, 2022
<ѻý>Cost-Analysis Fuels Debate on Transplant Waitlistsѻý> Without available kidneys, expense of longer lists not justified, researchers argue Mar 10, 2022
<ѻý>EHR 'Nudge' Linked to Fewer C. Diff Tests for Organ Transplant Recipientsѻý> The program also led to fewer days of antibiotics and cost savings Mar 07, 2022
<ѻý>E-Cig Use Tied to Higher Odds of Prediabetesѻý> As in regular cigarettes, nicotine may play a role, researcher says Mar 03, 2022
<ѻý>ARB-Cancer Link May Come Down to Cumulative Exposureѻý> Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022